Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Blood pressure control in hypertensive sleep apnoea patients of the European Sleep Apnea Database cohort - effects of positive airway pressure and antihypertensive medication

S. Svedmyr, J. Hedner, S. Bailly, F. Fanfulla, H. Hein, C. Lombardi, O. Ludka, S. Mihaicuta, G. Parati, A. Pataka, S. Schiza, S. Tasbakan, D. Testelmans, D. Zou, L. Grote, European Sleep Apnea Database (ESADA) study group

. 2023 ; 3 (6) : oead109. [pub] 20231017

Status not-indexed Language English Country England, Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc23022593

AIMS: We analysed longitudinal blood pressure (BP) data from hypertensive obstructive sleep apnoea (OSA) patients in the European Sleep Apnea Database cohort. The study investigated the interaction between positive airway pressure (PAP)-induced BP change and antihypertensive treatment (AHT). METHODS AND RESULTS: Hypertensive patients with AHT [monotherapy/dual therapy n = 1283/652, mean age 59.6 ± 10.7/60.6 ± 10.3 years, body mass index (BMI) 34.2 ± 6.5/34.8 ± 7.0 kg/m2, apnoea-hypopnoea index 46 ± 25/46 ± 24 n/h, proportion female 29/26%, respectively] started PAP treatment. Office BP at baseline and 2- to 36-month follow-up were assessed. The interaction between AHT drug classes and PAP on BP was quantified and the influences of age, gender, BMI, co-morbidities, BP at baseline, and study site were evaluated. Following PAP treatment (daily usage, 5.6 ± 1.6/5.7 ± 1.9 h/day), systolic BP was reduced by -3.9 ± 15.5/-2.8 ± 17.7 mmHg in mono/dual AHT and diastolic BP by -3.0 ± 9.8/-2.7 ± 10.8 mmHg, respectively, all P < 0.0001. Systolic and diastolic BP control was improved following PAP treatment (38/35% to 54/46% and 67/67% to 79/74%, mono/dual AHT, respectively). PAP treatment duration predicted a larger BP improvement in the monotherapy group. Intake of renin-angiotensin blockers [angiotensin converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB)] alone or in any AHT combination was associated with better BP control. The AHT-dependent BP improvement was independent of confounders. CONCLUSION: In this pan-European OSA patient cohort, BP control improved following initiation of PAP. Longer PAP treatment duration, was associated with a favourable effect on BP. Our study suggests that ACEI/ARB, alone or in combination with other drug classes, provides a particularly strong reduction of BP and better BP control when combined with PAP in OSA.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23022593
003      
CZ-PrNML
005      
20240116163058.0
007      
ta
008      
240105s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ehjopen/oead109 $2 doi
035    __
$a (PubMed)38035035
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Svedmyr, Sven $u Department of Sleep Medicine, Sahlgrenska University Hospital, Blå stråket 5, 413 45 Gothenburg, Sweden $u Center for Sleep and Vigilance Disorders, Sahlgrenska Academy, Gothenburg University, Medicinaregatan 8B, Box 421, 405 30 Gothenburg, Sweden $1 https://orcid.org/0000000257867938
245    10
$a Blood pressure control in hypertensive sleep apnoea patients of the European Sleep Apnea Database cohort - effects of positive airway pressure and antihypertensive medication / $c S. Svedmyr, J. Hedner, S. Bailly, F. Fanfulla, H. Hein, C. Lombardi, O. Ludka, S. Mihaicuta, G. Parati, A. Pataka, S. Schiza, S. Tasbakan, D. Testelmans, D. Zou, L. Grote, European Sleep Apnea Database (ESADA) study group
520    9_
$a AIMS: We analysed longitudinal blood pressure (BP) data from hypertensive obstructive sleep apnoea (OSA) patients in the European Sleep Apnea Database cohort. The study investigated the interaction between positive airway pressure (PAP)-induced BP change and antihypertensive treatment (AHT). METHODS AND RESULTS: Hypertensive patients with AHT [monotherapy/dual therapy n = 1283/652, mean age 59.6 ± 10.7/60.6 ± 10.3 years, body mass index (BMI) 34.2 ± 6.5/34.8 ± 7.0 kg/m2, apnoea-hypopnoea index 46 ± 25/46 ± 24 n/h, proportion female 29/26%, respectively] started PAP treatment. Office BP at baseline and 2- to 36-month follow-up were assessed. The interaction between AHT drug classes and PAP on BP was quantified and the influences of age, gender, BMI, co-morbidities, BP at baseline, and study site were evaluated. Following PAP treatment (daily usage, 5.6 ± 1.6/5.7 ± 1.9 h/day), systolic BP was reduced by -3.9 ± 15.5/-2.8 ± 17.7 mmHg in mono/dual AHT and diastolic BP by -3.0 ± 9.8/-2.7 ± 10.8 mmHg, respectively, all P < 0.0001. Systolic and diastolic BP control was improved following PAP treatment (38/35% to 54/46% and 67/67% to 79/74%, mono/dual AHT, respectively). PAP treatment duration predicted a larger BP improvement in the monotherapy group. Intake of renin-angiotensin blockers [angiotensin converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB)] alone or in any AHT combination was associated with better BP control. The AHT-dependent BP improvement was independent of confounders. CONCLUSION: In this pan-European OSA patient cohort, BP control improved following initiation of PAP. Longer PAP treatment duration, was associated with a favourable effect on BP. Our study suggests that ACEI/ARB, alone or in combination with other drug classes, provides a particularly strong reduction of BP and better BP control when combined with PAP in OSA.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hedner, Jan $u Department of Sleep Medicine, Sahlgrenska University Hospital, Blå stråket 5, 413 45 Gothenburg, Sweden $u Center for Sleep and Vigilance Disorders, Sahlgrenska Academy, Gothenburg University, Medicinaregatan 8B, Box 421, 405 30 Gothenburg, Sweden $1 https://orcid.org/000000027190394X
700    1_
$a Bailly, Sebastien $u Université Grenoble Alpes, INSERM HP2 (U1042) and Grenoble University Hospital, Grenoble, France
700    1_
$a Fanfulla, Francesco $u Unità Operativa di Medicina del Sonno, Istituto Scientifico di Pavia IRCCS, Pavia, Italy
700    1_
$a Hein, Holger $u Sleep Disorders Center, St.Adolf Stift, Reinbeck, Germany
700    1_
$a Lombardi, Carolina $u Cardiology Unit, Sleep Center, IRCCS Istituto Auxologico Italiano, Milan, Italy $u Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
700    1_
$a Ludka, Ondrej $u Department of Internal Medicine, University Hospital Brno, Brno, Czech Republic
700    1_
$a Mihaicuta, Stefan $u Center for Research and Innovation in Precision Medicine and Pharmacy, 'Victor Babes' University of Medicine and Pharmacy, Timisoara, Romania
700    1_
$a Parati, Gianfranco $u Cardiology Unit, Sleep Center, IRCCS Istituto Auxologico Italiano, Milan, Italy $u Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy $1 https://orcid.org/0000000194027439
700    1_
$a Pataka, Athanasia $u Respiratory Failure Unit, G. Papanikolaou Hospital, Aristotle University of Thessalonikii, Thessalonikii, Greece $1 https://orcid.org/0000000232526694
700    1_
$a Schiza, Sophia $u Sleep Disorders Unit, Department of Respiratory Medicine, School of Medicine, University of Crete, Crete, Greece
700    1_
$a Tasbakan, Sezai $u Department of Chest Diseases, Ege University, Izmir, Turkey $1 https://orcid.org/0000000345079851
700    1_
$a Testelmans, Dries $u Sleep Disorders Centre, University Hospital Gasthuisberg, Leuven, Belgium $1 https://orcid.org/0000000173039799
700    1_
$a Zou, Ding $u Department of Sleep Medicine, Sahlgrenska University Hospital, Blå stråket 5, 413 45 Gothenburg, Sweden $u Center for Sleep and Vigilance Disorders, Sahlgrenska Academy, Gothenburg University, Medicinaregatan 8B, Box 421, 405 30 Gothenburg, Sweden $1 https://orcid.org/0000000320578558
700    1_
$a Grote, Ludger $u Department of Sleep Medicine, Sahlgrenska University Hospital, Blå stråket 5, 413 45 Gothenburg, Sweden $u Center for Sleep and Vigilance Disorders, Sahlgrenska Academy, Gothenburg University, Medicinaregatan 8B, Box 421, 405 30 Gothenburg, Sweden $1 https://orcid.org/0000000274051682
710    2_
$a European Sleep Apnea Database (ESADA) study group
773    0_
$w MED00213975 $t European heart journal open $x 2752-4191 $g Roč. 3, č. 6 (2023), s. oead109
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38035035 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240105 $b ABA008
991    __
$a 20240116163055 $b ABA008
999    __
$a ok $b bmc $g 2036327 $s 1209038
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 3 $c 6 $d oead109 $e 20231017 $i 2752-4191 $m European heart journal open $n Eur Heart J Open $x MED00213975
LZP    __
$a Pubmed-20240105

Find record

Citation metrics

Archiving options